BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 20875136)

  • 1. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
    Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
    BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
    [No Abstract]   [Full Text] [Related]  

  • 5. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients.
    Kang EH; Kuwana M; Okazaki Y; Lee EY; Lee YJ; Lee EB; Song YW
    Mod Rheumatol; 2014 Nov; 24(6):945-8. PubMed ID: 24670134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
    Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y
    J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.
    Matsushita T; Hasegawa M; Fujimoto M; Hamaguchi Y; Komura K; Hirano T; Horikawa M; Kondo M; Orito H; Kaji K; Saito Y; Matsushita Y; Kawara S; Yasui M; Seishima M; Ozaki S; Kuwana M; Ogawa F; Sato S; Takehara K
    J Rheumatol; 2007 May; 34(5):1012-8. PubMed ID: 17309126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies.
    Misra AK; Wong NL; Healey TT; Lally EV; Shea BS
    BMC Pulm Med; 2021 Nov; 21(1):370. PubMed ID: 34775966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33916864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
    Hirakata M
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
    Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
    Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].
    Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
    Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
    Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.